1. Home
  2. JANX vs BLDP Comparison

JANX vs BLDP Comparison

Compare JANX & BLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$18.05

Market Cap

975.7M

Sector

Health Care

ML Signal

HOLD

Logo Ballard Power Systems Inc.

BLDP

Ballard Power Systems Inc.

HOLD

Current Price

$2.26

Market Cap

827.6M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
JANX
BLDP
Founded
2017
1979
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
975.7M
827.6M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
JANX
BLDP
Price
$18.05
$2.26
Analyst Decision
Buy
Hold
Analyst Count
13
6
Target Price
$47.00
$2.34
AVG Volume (30 Days)
670.8K
3.3M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,000,000.00
N/A
Revenue This Year
N/A
$14.53
Revenue Next Year
N/A
$18.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.12
$1.83
52 Week High
$35.34
$6.57

Technical Indicators

Market Signals
Indicator
JANX
BLDP
Relative Strength Index (RSI) 68.29 34.10
Support Level $13.13 $2.28
Resistance Level $35.34 $2.76
Average True Range (ATR) 0.64 0.10
MACD 0.20 0.01
Stochastic Oscillator 82.07 10.00

Price Performance

Historical Comparison
JANX
BLDP

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

About BLDP Ballard Power Systems Inc.

Ballard Power Systems Inc is engaged in design, development, manufacture, sale and service of proton exchange membrane ("PEM") fuel cell products for a variety of applications, focusing on power products for bus, truck, rail, marine, stationary and emerging market (material handling, off-road and other) applications, as well as the delivery of services, including technology solutions, after sales services and training. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. Key geographical revenue is derived from United States followed by Poland, Canada, and other countries.

Share on Social Networks: